|
Volumn 33, Issue 14, 2015, Pages 1622-
|
Clinical utility of circulating tumor cells in metastatic breast cancer
a a
a
INSTITUT CURIE
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN;
LAPATINIB;
TRASTUZUMAB;
TRASTUZUMAB EMTANSINE;
TUMOR MARKER;
ANTINEOPLASTIC AGENT;
BREAST METASTASIS;
CANCER CHEMOTHERAPY;
CANCER PROGNOSIS;
CANCER RESISTANCE;
CIRCULATING TUMOR CELL;
HUMAN;
LETTER;
OVERALL SURVIVAL;
POSITRON EMISSION TOMOGRAPHY;
PREVALENCE;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
TUMOR GROWTH;
BREAST NEOPLASMS;
DRUG SUBSTITUTION;
FEMALE;
PATHOLOGY;
TUMOR EMBOLISM;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
DRUG SUBSTITUTION;
FEMALE;
HUMANS;
NEOPLASTIC CELLS, CIRCULATING;
|
EID: 84933575887
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2014.57.9714 Document Type: Letter |
Times cited : (24)
|
References (5)
|